Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
0.3113
+0.0013 (0.42%)
Mar 11, 2026, 12:30 PM EDT - Market open

Cue Biopharma Revenue

Cue Biopharma had revenue of $2.15M in the quarter ending September 30, 2025, a decrease of -35.58%. This brings the company's revenue in the last twelve months to $7.10M, down -25.51% year-over-year. In the year 2024, Cue Biopharma had annual revenue of $9.29M with 69.16% growth.

Revenue (ttm)
$7.10M
Revenue Growth
-25.51%
P/S Ratio
4.27
Revenue / Employee
$173,171
Employees
41
Market Cap
30.34M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20249.29M3.80M69.16%
Dec 31, 20235.49M4.25M340.96%
Dec 31, 20221.25M-13.70M-91.67%
Dec 31, 202114.94M11.79M373.68%
Dec 31, 20203.15M-304.01K-8.79%
Dec 31, 20193.46M2.32M202.67%
Dec 31, 20181.14M--
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Kyntra Bio8.30M
Evaxion7.53M
Dyadic International3.34M
IGC Pharma1.11M
RenovoRx928.00K
Exicure500.00K
Hyperion DeFi345.32K
Revenue Rankings